Literature DB >> 22944319

Beta-adrenergic receptor activation primes microglia cytokine production.

John D Johnson1, Zachary R Zimomra, Luke T Stewart.   

Abstract

Exaggerated pro-inflammatory cytokine production by primed microglia is thought to mediate pathology during stress, aging, and neurodegeneration. Recently, it was demonstrated that beta-adrenergic receptor (β-AR) antagonism prevents priming of microglia in mice exposed to chronic stress. To determine if β-AR stimulation is sufficient to prime microglia, rats were intra-cerebroventricularly administered isoproterenol (β-AR agonist) or vehicle and 24 h later hippocampal microglia were placed in culture with media or LPS. Prior isoproterenol treatment significantly enhanced IL-1β and IL-6, but not TNF-α production following LPS stimulation. These data suggest that central β-AR stimulation is sufficient to prime microglia cytokine responses.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22944319     DOI: 10.1016/j.jneuroim.2012.08.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

Review 1.  Feeding the beast: can microglia in the senescent brain be regulated by diet?

Authors:  Rodney W Johnson
Journal:  Brain Behav Immun       Date:  2014-10-30       Impact factor: 7.217

2.  Sex differences in the regulation of brain IL-1β in response to chronic stress.

Authors:  David F Barnard; Kristin M Gabella; Adam C Kulp; Austin D Parker; Patrick B Dugan; John D Johnson
Journal:  Psychoneuroendocrinology       Date:  2019-01-25       Impact factor: 4.905

Review 3.  Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal.

Authors:  Michael D Weber; Jonathan P Godbout; John F Sheridan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

4.  Stress exacerbates neuron loss and microglia proliferation in a rat model of excitotoxic lower motor neuron injury.

Authors:  Denise A Puga; C Amy Tovar; Zhen Guan; John C Gensel; Matthew S Lyman; Dana M McTigue; Phillip G Popovich
Journal:  Brain Behav Immun       Date:  2015-06-19       Impact factor: 7.217

Review 5.  Microglia: Neuroimmune-sensors of stress.

Authors:  Matthew G Frank; Laura K Fonken; Linda R Watkins; Steven F Maier
Journal:  Semin Cell Dev Biol       Date:  2019-01-09       Impact factor: 7.727

6.  Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.

Authors:  Laura M Butkovich; Madelyn C Houser; Termpanit Chalermpalanupap; Kirsten A Porter-Stransky; Alexa F Iannitelli; Jake S Boles; Grace M Lloyd; Alexandra S Coomes; Lori N Eidson; Maria Elizabeth De Sousa Rodrigues; Danielle L Oliver; Sean D Kelly; Jianjun Chang; Nora Bengoa-Vergniory; Richard Wade-Martins; Benoit I Giasson; Valerie Joers; David Weinshenker; Malú Gámez Tansey
Journal:  J Neurosci       Date:  2020-08-31       Impact factor: 6.167

7.  Isoproterenol induced stressful reactions in the brain are characterized by inflammation due to activation of NADPH oxidase and ER stress: attenuated by Apocynin, Rehmannia complex and Triterpene acids.

Authors:  Guo-Long Mo; Ying Li; Rong-Hui Du; De-Zai Dai; Xiao-Dong Cong; Yin Dai
Journal:  Neurochem Res       Date:  2014-02-26       Impact factor: 3.996

Review 8.  Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.

Authors:  George R Breese; Darin J Knapp
Journal:  Alcohol       Date:  2016-02-24       Impact factor: 2.405

Review 9.  Microglia-Induced Maladaptive Plasticity Can Be Modulated by Neuropeptides In Vivo.

Authors:  Stefano Morara; Anna Maria Colangelo; Luciano Provini
Journal:  Neural Plast       Date:  2015-07-26       Impact factor: 3.599

Review 10.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.